[Early onset psychosis: rationale and concept of a cognitive-behavioral intervention]. / Jugendliche mit psychotischen Störungen: Rationale und Konzept einer kognitiv-verhaltenstherapeutischen Intervention.

Early onset psychoses (EOP, age of onset between age 14 and 18 years) are known to be associated with a poorer outcome than adult onset psychoses, both in terms of psychotic symptoms and social remission. For adult patients with psychosis, numerous cognitive-behavioral interventions have proven their effectiveness in recent years. This contrasts with a dearth of findings for EOP, even though it can be considered as a variant of adult onset psychosis. Thus, we have developed a cognitive-behavioral therapy intervention that was specifically adapted to the characteristics and needs of young people suffering from psychosis. The concept of the intervention is outlined in the present article. Acceptability and feasibility of the intervention are currently undergoing evaluation in a randomised, controlled pilot study.

[Assessing psychopathic personality disorders for legal procedures for using a version for adolescents of Hare's revised checklist]. / Erfassung von Persönlichkeitsdimensionen der Psychopathy nach Hare bei der strafrechtlichen Begutachtung von Jugendlichen. Eine retrospektive Untersuchung zur Anwendbarkeit der Psychopathy-Checkliste als Version für Jugendliche.

In accordance with Robert Hare's concept, the term psychopathy was operationalized in 1985 when the revised form of the psychopathy checklist (PCL-R) was published. Since then, the PCL-R has been used internationally. For several years in North America and now even in England and the Netherlands, personality traits of psychopathy have also been studied in children and juveniles. Based on the PCL-R, a checklist for adolescents (PCL-YV) was developed that takes the special conditions of adolescents into account. The goal of this paper was to test the applicability of the PCL-YV retrospectively in a sample of forensic psychiatric evaluations of delinquent juveniles that were assigned to the Clinic for Child and Adolescent Psychiatry at the University of Cologne, Germany. Based on results collected with the PCL-YV, data on groups of low- and medium-scoring juveniles were classified which partially differed significantly in relation to sociodemographic and anamnestic data. Furthermore, factor analyses showed a three-factor model solution. Associations with legal issues such as the question of criminal responsibility could not be found. In summary, the results indicate the applicability of the PCL-YV for adolescents but show the difficulties of retrospective design without conducting PCL interviews.

[The effectiveness of atomoxetine in children, adolescents, and adults with ADHD. A systematic overview]. / Wirksamkeit von Atomoxetin bei Kindern, Jugendlichen und Erwachsenen mit ADHS. Eine systematische Ubersicht.

This paper gives an overview of the pharmacology, efficacy, duration, tolerance, and side effects of atomoxetine for children, adolescents, and adults. A systematic analysis of the published clinical studies and poster abstracts was conducted. Atomoxetine is the first selective inhibitor of the noradrenaline transporter that was approved by the FDA in the US as a nonstimulant for the treatment of ADHD in children, adolescents, and adults. In clinical studies, its efficacy was studied in 4,000 patients. Compared with placebo, atomoxetine proved to be superior with respect to reducing impulsiveness, hyperactivity, and inattention. There are indications that its efficacy is comparable to that of methylphenidate. In general, atomoxetine was well tolerated. The most frequently reported adverse events were decrease of appetite, abdominal problems, tiredness, and vertigo. These were classified as mild and found mostly at the beginning of treatment. The existing results indicate that atomoxetine is promising for the treatment of ADHD in children, adolescents, and adults.

[The psychopathy-concept and its psychometric evaluation in childhood, adolescence and adulthood]. / Das Psychopathy-Konzept und seine psychometrische Erfassung im Kindes-, Jugend- und Erwachsenenalter.

The psychopathy concept in accordance with Robert Hare was operationalized in 1985 when the revised form of the Psychopathy Checklist (PCL-R) was published. Since then, the PCL-R has been used internationally in prognosis and therapy research. In North America, personality traits of psychopathy have also been studied in children and juveniles for several years by now. On the basis of the PCL-R, a checklist for adolescents (PCL-YV) was developed that takes the special conditions of adolescents into account. In juveniles with a high score research with the PCL-YV demonstrated a lack of empathy, impulsivity and social adjustment disorder. Furthermore, researchers found associations between the number and severity of violent offences, early drug abuse and earlier recidivism, i. e. repeated criminality. The biological determinants of these dimensions are discussed as well as associated questions about recent specific therapy concepts and diagnostic aspects of psychopathy in juveniles.

[Child is inattentive, cannot sit still, disturbs the classroom. Is it really a hyperkinetic disorder?]. / Kind ist unaufmerksam, kann nicht still sitzen, stört den Unterricht. Ist es wirklich eine hyperkinetische Störung?

The clarification of attention-deficit/hyperactivity disorder (ADHD) requires an unequivocal categorization of the diagnostic criteria and a differentiation of the condition from normal variations and other disorder patterns. The ICD-10 criteria comprise the main symptoms inattention, hyperactivity and impulsivity. In kindergarten and preschool children, hyperactivity predominates, while in schoolchildren poor attention and cognitive impulsivity tend to be to the fore. In adolescence, aggressiveness and dissocial behavior coupled with drug abuse become central. In adulthood, ADHD is associated in particular with a tendency towards a lower social status and more frequent delinquency. Establishment of the diagnosis of ADHD requires information from the person to whom the individual relates. In this connection, exploration schemas, check lists and questionnaires are often very helpful. With regard to the differential diagnosis, mental disturbances due to physical causes (e.g. hearing disorders, epilepsy, etc.) must be excluded. Consideration must also be given in particular to comorbidities--found in up to two-thirds of cases--in which disordered social behavior, affective disorders and anxiety disturbances dominate.

[Multimodal therapy concept in hyperkinetic disorder. Drugs alone are not enough]. / Multimodales Therapiekonzept bei hyperkinetischer Störung. Mit Medikamenten alleine ist es nicht getan.

For the treatment of attention deficit/hyperactivity disorder, both medical and behavioral therapeutic concepts have been shown to be effective. Somewhat problematical, however, is the fact that a large percentage of these children retain residual symptoms that need treating over a longer period of time. The value of a multimodal therapeutic approach (combination of medication and behavioral treatment including counseling of parents, teachers and the patient) remains controversial. Over the long-term, and account being taken of a number of indicators extending beyond the core symptoms, however, the multimodal treatment concept would appear superior to treatment solely with psychostimulants. For effective treatment accurate titration and the recording of the changes occurring under medication are important.